Mono Pharmacare Limited (NSE:MONOPHARMA)
India flag India · Delayed Price · Currency is INR
24.10
+0.60 (2.55%)
At close: Sep 12, 2025

Mono Pharmacare Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
423408779---
Upgrade
Market Cap Growth
-47.62%-47.62%----
Upgrade
Enterprise Value
9528941,134---
Upgrade
Last Close Price
23.9523.1044.10---
Upgrade
PE Ratio
13.6913.2131.90---
Upgrade
PS Ratio
0.250.240.64---
Upgrade
PB Ratio
1.351.312.77---
Upgrade
P/TBV Ratio
1.361.312.78---
Upgrade
EV/Sales Ratio
0.570.530.93---
Upgrade
EV/EBITDA Ratio
12.2011.4617.72---
Upgrade
EV/EBIT Ratio
12.4011.6518.05---
Upgrade
Debt / Equity Ratio
1.721.721.472.921.511.65
Upgrade
Debt / EBITDA Ratio
6.866.866.4817.374.636.34
Upgrade
Debt / FCF Ratio
----28.52-
Upgrade
Asset Turnover
1.761.761.700.862.902.85
Upgrade
Inventory Turnover
3.123.122.951.567.857.50
Upgrade
Quick Ratio
0.810.810.890.660.670.84
Upgrade
Current Ratio
2.072.072.241.821.641.66
Upgrade
Return on Equity (ROE)
10.46%10.46%11.76%10.52%8.80%3.33%
Upgrade
Return on Assets (ROA)
5.02%5.02%5.47%3.65%6.27%5.21%
Upgrade
Return on Capital (ROIC)
6.21%6.21%6.38%4.37%7.83%5.73%
Upgrade
Return on Capital Employed (ROCE)
13.40%13.40%13.90%7.70%22.20%17.70%
Upgrade
Earnings Yield
7.30%7.57%3.14%---
Upgrade
FCF Yield
-10.70%-11.10%-11.48%---
Upgrade
Buyback Yield / Dilution
-15.09%-15.09%-171.01%-15.18%--
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.